Navigation Links
Filling a Niche -- Role of Rb in Mammalian Stem Cells

Drs. Gustavo Leone and Michael Robinson (Ohio State University) and colleagues uncover a stem-cell specific role for the well-known tumor suppressor gene// , Rb, in the developing mammalian embryo.

Researchers had previously shown that mice deficient in Rb die as embryos. Using a combination of sophisticated mouse genetics and 3D computer modeling, OSU scientists have now determined why: Rb is required for the maintenance of the trophoblast stem cell population, which is essential for forming the placenta. Specific loss of Rb in trophoblast stem cells results in an overexpansion of trophoblast cells, aberrant placental formation, and embryonic death.

These findings implicate a role for the Rb pathway in the development of the human placenta and may provide a link between Rb, and possibly other cell cycle regulators, and pregnancy-related complications such as miscarriages and pre-eclempsia.

The demonstration that Rb tumor suppressor function is critical in trophoblast stem cells of the placenta will also certainly fuel the emerging hypothesis that stem-like cells may serve as a repository in which tumor suppressor function is critical to prevent cancer.

Source-Eurekalert
'"/>




Page: 1

Related medicine news :

1. Safety Of Dental Amalgam Fillings To Be Reviewed
2. First Major Study of Mammalian “Disorderly” Proteis
3. Cannibalistic Signals Help Mammalian Embryos Develop Normally
4. Blood Cells Capable of Regenerating Liver
5. White Cells Count Can Predict Heart Attack Death Risk
6. Gene Therapy Destroys Pancreatic Cancer Cells
7. Stem Cells Have Few Mutations
8. Heart may pull Cells from Body to Self-repair
9. Cells critical for asthma development found
10. Vitamin D Wipes out Cancer Cells
11. Bone Marrow Cells Help Heart Attack Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Filling Niche Role Mammalian Stem Cells

Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Celator 28R 29 Pharmaceuticals Presents Data on the Activity of CPX 351 Against Leukemia at the European Hematology Association Congress 12509 1Celator 28R 29 Pharmaceuticals Presents Data on the Activity of CPX 351 Against Leukemia at the European Hematology Association Congress 12509 2Celator 28R 29 Pharmaceuticals Presents Data on the Activity of CPX 351 Against Leukemia at the European Hematology Association Congress 12509 3Rights Access to Healthcare Providers of Choice at Risk 48146 1Rights Access to Healthcare Providers of Choice at Risk 48146 2Rights Access to Healthcare Providers of Choice at Risk 48146 3Generic Erosion Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by 241 8 Billion from 2008 to 2018 48141 1Generic Erosion Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by 241 8 Billion from 2008 to 2018 48141 2